11/13/2024 6:15 AM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024 6:00 AM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/21/2024 6:31 AM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024 4:00 PM | Entero Therapeutics, Inc. (Issuer) Entero Therapeutics, Inc. (Issuer) Entero Therapeutics (Issuer) Romano Sarah (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 4:10 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/10/2024 6:00 AM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/29/2024 3:05 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
08/23/2024 4:00 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/22/2024 4:28 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2024 7:00 AM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2024 7:05 AM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form NT 10-Q | |
08/14/2024 8:46 PM | Entero Therapeutics, Inc. (Issuer) Entero Therapeutics, Inc. (Issuer) Entero Therapeutics (Issuer) Ramdeen Timothy R. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/07/2024 4:20 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2024 9:54 AM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2024 3:16 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
07/23/2024 3:05 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2024 7:00 AM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2024 1:33 PM | Entero Therapeutics, Inc. (Issuer) Entero Therapeutics, Inc. (Issuer) Entero Therapeutics (Issuer) SAPIRSTEIN JAMES (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 1:34 PM | Entero Therapeutics, Inc. (Issuer) Entero Therapeutics, Inc. (Issuer) Entero Therapeutics (Issuer) Romano Sarah (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 7:03 AM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/20/2024 3:30 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 4:23 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form PRER14A | |
06/14/2024 4:15 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 424B3 | |
06/12/2024 5:23 PM | Entero Therapeutics, Inc. (Issuer) Entero Therapeutics, Inc. (Issuer) Entero Therapeutics (Issuer) KHOSLA CHAITAN PHD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 11:15 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form EFFECT | |
06/05/2024 4:15 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2024 4:25 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
05/30/2024 4:18 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K/A | |
05/30/2024 4:32 PM | Entero Therapeutics, Inc. (Filer) Entero Therapeutics, Inc. (Filer) Entero Therapeutics (Filer)
| Form DEFA14A | |
05/16/2024 6:16 AM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 4:26 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024 4:26 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 3:59 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 424B5 | |
05/08/2024 4:16 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K/A | |
03/29/2024 3:16 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/22/2024 4:00 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 3:40 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 3:31 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form DEFA14A | |
03/15/2024 5:00 PM | First Wave BioPharma, Inc. (Issuer) First Wave BioPharma, Inc. (Issuer) Entero Therapeutics (Issuer) Syage Jack (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/15/2024 5:00 PM | First Wave BioPharma, Inc. (Issuer) First Wave BioPharma, Inc. (Issuer) Entero Therapeutics (Issuer) KHOSLA CHAITAN PHD (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/15/2024 5:05 PM | First Wave BioPharma, Inc. (Issuer) First Wave BioPharma, Inc. (Issuer) Entero Therapeutics (Issuer) KHOSLA CHAITAN PHD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Central Bank Abandons USD (Ad) You know what doesn't care about elections? Gold.
If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD!
Get Your FREE Gold Investor Kit NOW! |
03/15/2024 5:05 PM | First Wave BioPharma, Inc. (Issuer) First Wave BioPharma, Inc. (Issuer) Entero Therapeutics (Issuer) Syage Jack (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 5:10 AM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form DEFA14A | |
03/14/2024 5:09 AM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 4:29 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 424B5 | |
02/14/2024 1:45 PM | ARMISTICE CAPITAL, LLC (Filed by) First Wave BioPharma, Inc. (Subject) First Wave BioPharma, Inc. (Subject) Entero Therapeutics (Subject)
| Form SC 13G/A | |
01/17/2024 11:15 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form EFFECT | |
01/08/2024 4:14 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/04/2024 4:12 PM | BORKOWSKI EDWARD (Reporting) First Wave BioPharma, Inc. (Issuer) First Wave BioPharma, Inc. (Issuer) Entero Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 4:13 PM | Coelho Mary Theresa (Reporting) First Wave BioPharma, Inc. (Issuer) First Wave BioPharma, Inc. (Issuer) Entero Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 4:13 PM | First Wave BioPharma, Inc. (Issuer) First Wave BioPharma, Inc. (Issuer) Entero Therapeutics (Issuer) Riddell Alastair (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 4:14 PM | CASAMENTO CHARLES J (Reporting) First Wave BioPharma, Inc. (Issuer) First Wave BioPharma, Inc. (Issuer) Entero Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 7:22 AM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 6:54 PM | First Wave BioPharma, Inc. (Issuer) First Wave BioPharma, Inc. (Issuer) Entero Therapeutics (Issuer) Romano Sarah (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:55 PM | First Wave BioPharma, Inc. (Issuer) First Wave BioPharma, Inc. (Issuer) Entero Therapeutics (Issuer) SAPIRSTEIN JAMES (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 11:21 AM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form RW | |
12/27/2023 4:23 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2023 7:04 AM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form S-1/A | |
12/27/2023 5:15 AM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 6:00 AM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/15/2023 8:48 PM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form S-1/A | |
12/14/2023 8:15 AM | First Wave BioPharma, Inc. (Filer) First Wave BioPharma, Inc. (Filer) Entero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |